Oral 5‑aminolevulinic acid for overactive bladder: a double‑blind, randomized, placebo‑controlled pilot trial

Abstract Background 5-Aminolevulinic acid (5-ALA) reportedly improves overactive bladder (OAB) symptoms by reducing reactive oxygen species derived from vascular endothelial cells to protect vascular function and enhance bladder blood flow and by inhibiting bladder C-fiber activity. This double-blin...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Satoshi Fukata, Nobutaka Shimizu, Takahira Kuno, Rie Yoshimura, Hiroki Sugimoto, Ayano Kawaguchi, Yoshitaka Kurano, Daigo Takemori, Shinkuro Yamamoto, Taeko Nishioka, Natsuko Nakamura, Hajime Kuroiwa, Hiroko Iijima, Takashi Karashima, Keiji Inoue
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2026-02-01
Serier:	European Journal of Medical Research
Fag:	5-ALA Overactive bladder OABSS Residual urine volume
Online adgang:	https://doi.org/10.1186/s40001-026-04113-5
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!